Bibliographic Details
Title: |
Final Results of a CTEP Sponsored Phase I Study of Alistertib in Combination with Bortezomib and Rituximab in Relapsed and Refractory Mantle Cell and Low Grade Non-Hodgkin Lymphoma |
Authors: |
Barta, Stefan Klaus, Kornblum, Noah *, Raphael, Bruce G., Hymes, Kenneth B., Grossbard, Michael L., Moskovits, Tibor, Handorf, Elizabeth *, Sparano, Joseph *, Piekarz, Richard *, Diefenbach, Catherine |
Source: |
In Blood 29 November 2018 132 Supplement 1:4166-4166 |
Database: |
ScienceDirect |